SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?


To: OpusX who wrote (1089)4/7/1999 4:26:00 PM
From: ubrx  Read Replies (1) | Respond to of 1837
 
Hello Robert,
Yet another pharmacist here. I took a small position in DRMD today (8-15/16). Short term it would not surprise me at all if we drifted lower. I will add to my position if we see a share price under $8 (on no news) in the near future. Longer term, I think that Cenestin will get a good percentage of the estrogen replacement market but it will take time and money.

Good Luck.
Jim